Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
225,970,109
-
Total 13F shares
-
227,218,938
-
Share change
-
-507,013
-
Total reported value
-
$62,202,902,147
-
Put/Call ratio
-
51%
-
Price per share
-
$274.05
-
Number of holders
-
935
-
Value change
-
-$82,133,140
-
Number of buys
-
374
-
Number of sells
-
447
Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q3 2018
As of 30 Sep 2018,
Elevance Health, Inc. - Common Stock (ELV) was held by
935 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
227,218,938 shares.
The largest 10 holders included
BlackRock Inc., Vanguard Group Inc, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, FMR LLC, Viking Global Investors LP, WELLINGTON MANAGEMENT GROUP LLP, BAILLIE GIFFORD & CO, Invesco Ltd., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
936
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.